|
Home>Faculty
List >Dr. Schechter
|
Norman M. Schechter, Ph.D. |
Education
1969 B.S. State
University of New York at Stony Brook
1975 Ph.D. Duke University,
Durham, NC
Research Area of Interests
Structure and function of Serine Proteases and their inhibitors
Summary of Current Research Aims
The major research interests of the laboratory are in the structure,
function, and regulation of serine proteases and serine protease inhibitors.
Research concentrates on two human serine proteinases termed tryptase
and chymase. Both are found in high abundance within the secretory granules
of inflammatory cells known as mast cells. High yield recombinant expression
of both proteases has made it possible to study their structural and
functional properties in detail. The x-ray crystal structure of human
chymase bound to a peptide inhibitor was determined; this structure
allows for an understanding of the enzyme at the molecular level.
Both proteases have a number of unusual properties that make their study
of interest. Tryptase is a tetramer composed of 4 catalytic subunits,
has no physiological inhibitor to regulate its proteolytic activity,
and spontaneously inactivates in solutions of physiological pH, salt
and temperature, unless in the presence of a highly sulfated GAG such
as heparin. The structural reasons for tryptase's functional instability
and how sulfated GAGs stabilize the protease are being pursued. Rescue
of inactivated tryptase by heparin, small strong-binding inhibitors,
and high salt suggests that the inactivation process is reversible and
is produced by a limited structural change.
The biological role of chymase (and tryptase) is uncertain. The x-ray
crystal structure of the chymase-peptide inhibitor complex demonstrates
an extraordinary number of charged residues in the active site as well
as the unusual orientation of a highly conserved phenylalanine residue.
These residues may be factors in determining the substrate specificity
of the protease. Their role in the hydrolysis of substrates and in the
interaction of chymase with protease inhibitors is being explored using
site directed-mutagenesis.
The mechanism of protease inhibition by members of the serpin family
is controversial appearing to depend on the trapping of the enzyme in
a covalent complex resulting from incomplete hydrolysis of the reactive
center peptide bond. Cleavage of the inhibitor proceeds only to the
formation of the serpin acyl-enzyme complex, a species believed comparable
to the acyl-enzyme intermediate in substrate hydrolysis. Inactivation
of chymase by certain serpins deviates from this mechanism in two ways:
1) inactivation occurs with an unusually high stoichiometry of inhibition
indicating a partitioning step that produces cleaved-inactivated inhibitor
in a substrate-like manner, and 2) the rate constant of inhibition does
not reveal the kind of pH dependence expected if formation of the serpin
acyl-enzyme complex is rate limiting. Chymase-serpin complexes are extremely
stable and physical studies show that the enzyme is altered structurally
in the complex. Establishing the critical step producing the partitioning
of the reaction, the reason for the unexpected pH dependence, and the
specific structural changes in chymase producing stable complex formation
are being explored to define the mechanism of serpin inhibition.
Dr. Schechter's Lab Personnel:
Trevor Selwood, Ph.D., Senior Research Scientist
Eun-Jung Choi, Research Specialist
Selected
Publications
Selwood, T., Smolensky, H, McCaslin, D. R. and Schechter, N. M. The interaction of human tryptase-beta with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease. Biochemistry 44: 3580-3590, (2005)
Plotnick, M I, Rubin, H, Schechter, N. M., The effects of reactive site location on the inhibitory properties of the serpin alpha-1-antichymotrypsin. J. Biol. Chem. 277: 29927-29935 (2002)
Pereira, P. J. B., Wang, Z-m, Rubin, H., Huber, R., Bode, W., Schechter, N. M. and Stobl, S. The 2.2 A crystal structure of human chymase in complex with succinly-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J. Mol. Biol. 286: 163-173, 1999
Wang Z-m , Walter, M., Selwood, T., Rubin, H., and Schechter, N. M. Recombinant expression of human mast cell proteases chymase and tryptase. Biol. Chem. 379: 167-174, 1998
Schechter, N. M., Brass, L. F., Lavker, R. M. and Jensen, P. J., Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J. Cellular Physiol. 176: 365-373, 1998
|
Privacy Statement | Legal
Disclaimer
The University of Pennsylvania Health System. © 2005. The Trustees of University of Pennsylvania |